Zhejiang Canaan Technology Co., Ltd. Class A

Zhejiang Canaan Technology Co., Ltd. Class A

SSZSE:300412
3.72
CNY
-0.07
(-1.85%)
0.04EPS
171.62P/E
2.26BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.52
0.46
0.55
0.75
1.01
1.32
1.61
2.27
2.3
2.2
2.23
2.67
2.49
2.35
Basic EPS, GAAP
0.12
0.11
0.13
0.14
0.1
0.08
0.12
0.15
0.16
-0.15
-0.05
0.07
0.06
0.03
Free Cash Flow per Basic Share
-0.01
0.07
0.04
0.01
-0.23
-0.17
0.06
-0.06
-0.17
-0.19
-0.49
0.13
0.29
- -
Dividend per Share
0.02
0.02
0.04
0.12
0.07
0.07
0.07
0.1
0.1
0.05
0.02
0.03
0.09
0.08
Book Value per Share
0.57
0.89
0.98
1.68
1.75
1.78
1.81
1.92
2.27
2.09
2.04
2.11
2.11
2.04
Tangible Book Value per Share
0.51
0.86
0.88
1.51
1.44
1.48
1.55
1.54
2
1.81
1.77
1.86
1.87
1.81
Basic Weighted Avg Shares
299
404
398
404
440
440
436
444
461
501
469
518
494
489
Sales/Revenue/Turnover
154
184
217
302
445
579
703
1,007
1,060
1,103
1,047
1,383
1,231
1,149
Operating Margin (%)
24.87
25.67
24.56
20.99
12.64
12.57
13.31
10.82
9.59
2.57
1.56
5.3
4.07
2.68
Depreciation Expense
6
7
9
9
12
17
20
22
34
36
46
51
55
- -
Net Income, GAAP
35
43
51
57
44
34
51
68
74
-75
-23
36
30
13
Effective Tax Rate (%)
13.62
13.8
13.77
14.55
16.47
13.55
23.52
12.8
13.4
- -
- -
14.82
- -
- -
Profit Margin (%)
22.51
23.26
23.67
18.9
9.88
5.81
7.3
6.74
6.96
-6.82
-2.24
2.62
2.41
1.12
Working Capital
66
246
234
535
471
470
499
498
748
505
456
477
451
488
LT Debt
- -
- -
- -
- -
- -
- -
- -
30
132
114
192
183
114
154
Total Equity
170
357
397
764
815
837
839
887
1,188
1,083
1,056
1,082
1,090
1,060
Return on Invested Capital (%)
17.82
13.76
11.32
8.53
5.93
5.34
6.57
7.99
7.16
- -
- -
2.18
- -
- -
Return on Capital (%)
19.57
15.26
12.52
9.1
5.06
2.72
5.14
6.23
5.13
- -
- -
3.69
- -
- -
Return on Common Equity (%)
22.3
16.22
13.71
10.07
5.8
4.31
6.49
8.31
7.48
-6.93
-2.28
3.51
2.82
1.26

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
378
263
264
LT Borrowings
93
136
146
LT Finance Leases
6
6
9
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
498
498
498
Market Capitalization
2,588
2,270
2,260

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,776
1,734
1,923
Cash, Cash Equivalents & STI
468
392
484
Accounts Receivable, Net
304
354
363
Inventories
729
755
888
Total Current Liabilities
1,347
1,264
1,436
Payables & Accruals
- -
- -
- -
ST Debt
378
263
264
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.38%
5.17%
0.74%
Free Cash Flow
-198.3%
71.53%
123.12%
Net Income, GAAP
-48.6%
-107.08%
-18.27%
Sales/Revenue/Turnover
20.64%
5.07%
-10.98%
Total Cash Common Dividend
32.07%
22.73%
174.86%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
219
334
298
533
1,383
2025
246
314
- -
406
1,231
2026
130
372
242
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
0.04
0.01
0.04
0.07
2025
-0.01
0.02
- -
0.04
0.06
2026
-0.02
0.01
-0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
0.01
0.03
2025
0.01
0.07
- -
- -
0.09
2026
0.01
0.06
- -
- -
- -

Company Description

CEO
Zheng Fang
Full Time Employees
1,582
Sector
Health technology
Industry
Medical specialties
Address
No. 1188, Jiangnan Avenue Wenzhou ZH China 325102
IPO Date
Dec 18, 2014
Business
Zhejiang Canaan Technology Limited (300412.SZ) manufactures and sells pharmaceutical equipment principally for the solid dosage preparation sector. The company offers powder process equipment including high shear mixers and roller compactors; solid dosage equipment such as fluid bed dryers, blenders, tablet presses, and coaters; traditional Chinese medicine extraction equipment; fluid process equipment; intelligent logistics systems; API systems comprising filtration, crystallization, and agitated nutsche filter dryers; packaging lines; water systems; isolators for OEB4/5 containment; and comprehensive solutions encompassing EPCMV engineering services, solid preparation lines, API lines, smart packaging, warehousing logistics, R&D services, and digitalization platforms. Founded in 2000 and headquartered in Wenzhou, China, Zhejiang Canaan Technology operates primarily in China with international reach across pharmaceutical, food, nutraceutical, fine chemical, new energy, and new materials industries. In 2024, the company achieved a 32% revenue increase to CNY 1.383 billion alongside a net profit turnaround to CNY 36.2 million; its subsidiary Yunnan Canaan Feiqi Technology received high-tech enterprise certification in November 2024.